What Genesys AI Labs does
Founded in 2023, Genesys AI Labs operates in Health Tech industry. The company's flagship product 'Miracle' is an AI tool that predicts the best viable embryos for successful IVF, significantly reducing human errors and improving success rates by 25% over conventional methods. Additionally, the company has launched 'PIXELATOR', a digital pathology platform aimed at enhancing the diagnostic workflow for pathologists and lab professionals. Genesys AI Labs focuses on increasing the efficiency and transparency of medical diagnostics while aiming to reduce IVF cycles, costs, and patient trauma. The company's embryo classification prediction boasts an accuracy of 94%.
Who runs it
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Genesys AI Labs yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.